Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health.
Adiposity
/ ethnology
Adult
Cardiometabolic Risk Factors
Cardiovascular Diseases
/ epidemiology
Chronic Disease
/ epidemiology
Czech Republic
/ epidemiology
Diabetes Mellitus, Type 2
/ epidemiology
Diet
/ adverse effects
Dyslipidemias
/ epidemiology
Feeding Behavior
/ ethnology
Female
Glucose Intolerance
/ epidemiology
Health Literacy
Health Status Disparities
Humans
Hypertension
/ epidemiology
Male
Metabolic Syndrome
/ epidemiology
Middle Aged
Obesity
/ epidemiology
Prediabetic State
/ epidemiology
Prevalence
Sedentary Behavior
/ ethnology
Social Determinants of Health
/ ethnology
White People
/ statistics & numerical data
adiposity
cardiometabolic risk
cardiovascular disease
chronic disease
dysglycemia
insulin resistance
nutrition
obesity
type 2 diabetes
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
08 Jul 2021
08 Jul 2021
Historique:
received:
08
06
2021
revised:
28
06
2021
accepted:
05
07
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
8
9
2021
Statut:
epublish
Résumé
In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.
Identifiants
pubmed: 34371848
pii: nu13072338
doi: 10.3390/nu13072338
pmc: PMC8308692
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Regional Development Fund
ID : CZ.1.05/1.1.00/02.0123
Organisme : National Program of Sustainability II (MEYS CR)
ID : LQ1605
Organisme : ENOCH
ID : CZ.02.1.01/0.0/0.0/16_019/0000868
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NT13434-4/2012
Références
Diabetes Ther. 2018 Oct;9(5):1897-1906
pubmed: 30094784
Ann Glob Health. 2020 Feb 26;86(1):21
pubmed: 32166066
J Am Coll Cardiol. 2020 Oct 27;76(17):2024-2035
pubmed: 33092738
Cas Lek Cesk. 2016 Fall;155(5):233-241
pubmed: 27696885
Endocr Pract. 2018 Nov;24(11):995-1011
pubmed: 30763128
Health Lit Res Pract. 2018 Apr 12;2(2):e67-e77
pubmed: 31294279
Diabetes Ther. 2018 Apr;9(2):665-672
pubmed: 29460257
J Gen Intern Med. 2013 Mar;28(3):444-52
pubmed: 23065575
Eur J Nutr. 2021 Mar;60(2):1091-1100
pubmed: 32613328
Physiol Res. 2011;60(1):199-202
pubmed: 20945953
Public Health. 2018 Mar;156:8-14
pubmed: 29353668
Endocr Pract. 2021 May;27(5):455-462
pubmed: 33685667
Diabetologia. 2010 Apr;53(4):600-5
pubmed: 20012011
Health Syst Transit. 2015 Jan;17(1):1-165
pubmed: 26106825
J Am Coll Cardiol. 2020 Feb 11;75(5):525-538
pubmed: 32029136
Patient Prefer Adherence. 2019 Mar 15;13:395-407
pubmed: 30936685
Eur J Prev Cardiol. 2020 Apr 07;:
pubmed: 33611446
Int J Integr Care. 2000 Nov 01;1:e06
pubmed: 16902697
Cent Eur J Public Health. 2019 Dec;27 Suppl:S15-S28
pubmed: 31901189
Physiol Res. 2011;60(1):175-83
pubmed: 20945952
Clin Chem Lab Med. 2009;47(4):387-90
pubmed: 19278366
Clin Biochem. 2013 Mar;46(4-5):313-6
pubmed: 23201545
Folia Biol (Praha). 2013;59(3):123-33
pubmed: 23890480
Mayo Clin Proc Innov Qual Outcomes. 2019 Aug 23;3(3):268-275
pubmed: 31485564
BMC Public Health. 2019 Dec 12;19(1):1677
pubmed: 31830956
Nutr Metab Cardiovasc Dis. 2020 Jun 9;30(6):896-906
pubmed: 32249142
Gene. 2018 Feb 5;642:220-224
pubmed: 29154870
Nutrients. 2021 Jan 14;13(1):
pubmed: 33466692
J Clin Endocrinol Metab. 2007 Sep;92(9):3689-96
pubmed: 17579204
Diabetes Educ. 2019 Aug;45(4):431-441
pubmed: 31226913
N Engl J Med. 2019 Dec 26;381(26):2541-2551
pubmed: 31881139
Nat Rev Endocrinol. 2021 Mar;17(3):135-149
pubmed: 33479538
Diabet Med. 2005 Oct;22(10):1379-85
pubmed: 16176200
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S206-25
pubmed: 19888275
Nutrients. 2020 Sep 17;12(9):
pubmed: 32957567
Folia Biol (Praha). 2010;56(3):131-4
pubmed: 20653998
J Epidemiol Community Health. 2018 May;72(5):442-448
pubmed: 29439193
PLoS One. 2020 May 11;15(5):e0232845
pubmed: 32392239
Endocrinol Metab Clin North Am. 2016 Sep;45(3):677-88
pubmed: 27519139
Eur J Sport Sci. 2014;14(2):193-8
pubmed: 23889330
Eur J Prev Cardiol. 2018 Jan;25(1):54-64
pubmed: 28812915
Obes Sci Pract. 2021 May 05;7(5):535-544
pubmed: 34631132
Diabetes Res Clin Pract. 2020 Dec;170:108470
pubmed: 32998019
Physiol Res. 2015;64(Suppl 3):S419-26
pubmed: 26680676
Cent Eur J Public Health. 2010 Jun;18(2):63-9
pubmed: 20939254
Cas Lek Cesk. 2006;145(12):936-42
pubmed: 17323616
J Diabetes Sci Technol. 2011 Sep 01;5(5):1124-36
pubmed: 22027305
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
PLoS One. 2020 Nov 30;15(11):e0242487
pubmed: 33253259
Folia Biol (Praha). 2010;56(3):116-23
pubmed: 20653996
Endocr Pract. 2017 Mar;23(3):372-378
pubmed: 27967229